Lexapro Does NOT Cause Overactive Bladder—It May Actually Worsen Urinary Retention
Lexapro (escitalopram) is not associated with causing overactive bladder (OAB) symptoms. In fact, the opposite is true: Lexapro can cause urinary retention, not urgency or frequency. The FDA-approved drug label for Lexapro does not list OAB symptoms among its side effects 1.
What the Evidence Shows
FDA Drug Label Findings
The official Lexapro prescribing information lists common side effects including trouble sleeping, sweating, decreased sex drive, nausea, and tiredness—but no mention of urinary urgency, frequency, or other OAB symptoms 1. This is critical because FDA labels represent the most authoritative source for known drug effects.
The Actual Urinary Side Effect: Retention, Not OAB
Multiple case reports and research studies demonstrate that escitalopram causes the opposite problem—acute urinary retention (AUR):
- Case series in elderly men with benign prostatic hyperplasia showed development of AUR after starting standard-dose escitalopram, with symptoms resolving after discontinuation 2
- Individual case reports document AUR developing shortly after escitalopram initiation, resolving only after stopping the medication 3
- Mechanistic studies reveal escitalopram directly inhibits detrusor (bladder muscle) contractility by blocking L-type calcium channels, which would impair bladder emptying rather than cause overactivity 4
The Paradoxical Research Finding
Interestingly, one animal study found that escitalopram actually improved OAB symptoms in rats with corticosterone-induced depression and OAB, performing better than standard OAB medications like solifenacin and mirabegron 5. However, this was in a specific experimental model of co-occurring depression and OAB, not in patients taking escitalopram who then developed OAB.
Clinical Implications
What to Monitor
If a patient on Lexapro reports urinary symptoms, consider:
- Urinary retention or incomplete emptying (difficulty starting urination, weak stream, feeling of incomplete bladder emptying)
- NOT typical OAB symptoms (urgency, frequency, nocturia, urgency incontinence)
High-Risk Populations
Escitalopram-induced urinary retention is particularly concerning in:
- Elderly men with known or latent benign prostatic hyperplasia 2
- Patients with pre-existing bladder outlet obstruction
- Those on other medications with anticholinergic properties
If OAB Symptoms Develop
If a patient on Lexapro develops true OAB symptoms (urgency, frequency), do not assume Lexapro is the cause. Instead:
- Evaluate for other causes per standard OAB guidelines 6
- Consider that depression itself may be associated with higher OAB prevalence 7
- Follow the AUA/SUFU guideline algorithm: behavioral therapies, then beta-3 agonists or antimuscarinics, then minimally invasive procedures 6
Important Caveat
One observational study found higher OAB prevalence in women taking various antidepressants (64% vs 33% in controls), with fluoxetine showing the highest rate 7. However, this study did not specifically isolate escitalopram's effects and likely reflects the complex relationship between depression and bladder symptoms rather than a direct drug effect causing OAB.
Bottom line: Lexapro causes urinary retention through direct bladder muscle inhibition, not OAB symptoms. If OAB develops in a patient taking Lexapro, investigate other causes rather than attributing it to the medication.